ArticleGynecologic oncology2013
Targeting CD133 in an in vivo ovarian cancer model reduces ovarian cancer progression.
Amy P N Skubitz et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
55 papers cite it
this paperpooled itcites it